Booth videos for 510(k)-pending and investigational devices

FDA policy (CPG Sec. 300.600) lets a firm advertise or display a device with a pending 510(k), but not take orders or be prepared to take orders for it. An investigational device can't be promoted or called safe or effective (21 CFR 812.7). At a scientific meeting you may post a limited notice of availability with the caution statement, "Caution: Investigational device, limited by Federal (or United States) law to investigational use," shown at least as large as the largest text. So a booth loop for a pending device can show the product and its proposed use with a clear status line and no order path.
Show season puts a lot of devices on the floor before they can be sold in the US. Some are waiting on a 510(k) decision. Some are still in a clinical study under an IDE. The booth loop for those products gets written the same way as every other loop, then gets stopped in review because nobody checked which rules apply to a device that isn't cleared yet.
The rules are older than most booth hardware, and they are short. This guide covers what FDA policy allows for a 510(k)-pending device and for an investigational device, what that means line by line for a booth video, and a checklist you can run on a script this week. If your team is exhibiting at RSNA 2026 (Nov. 29 to Dec. 3 at McCormick Place in Chicago, with technical exhibits open Nov. 29 to Dec. 2), there is still time to get this right.
Two different rules for two different statuses
"Not cleared yet" covers two situations that FDA treats differently. Sort your device into one of them before anyone writes a script.
You may display and advertise
FDA's Compliance Policy Guide Sec. 300.600, first issued in 1978 and reissued in 1980 and 1987, says a firm may advertise or display a device that is the subject of a pending 510(k). The limit is commercial: the firm may not take orders, or be prepared to take orders, that might result in contracts of sale, unless they are limited to research or investigational use.
You may not promote
21 CFR 812.7 bars a sponsor, investigator, or anyone acting for them from promoting or test marketing an investigational device until FDA has approved it for commercial distribution. It also bars representing that the device is safe or effective for the purposes under investigation.
Two edge cases matter. The CPG speaks only to pending 510(k)s, so a device with a pending PMA needs its own answer from your regulatory team. And if a 510(k) relied on an IDE study, a 1997 MD&DI column on display policy argued that the investigational rules likely take priority, so following them is the safer course. Ask your regulatory team which bucket your product is in, in writing, and put the answer at the top of the script.
What a booth video can show for a 510(k)-pending device
For a 510(k)-pending device, the video can show the product, how it works and the use you have asked FDA to clear. What it cannot do is invite a purchase. That sounds simple, but booth loops are written to drive conversations that end in a quote, so the sales language creeps in.
| Element | Cleared device | 510(k) pending | Investigational |
|---|---|---|---|
| Product visuals and animation | Yes | Yes | Only as part of a limited notice, if at all |
| Intended use statement | Cleared indications | The proposed use in the submission, no broader | Proposed use only, framed as under investigation |
| Performance or outcome claims | Supported and on-label | Only what matches the pending submission, reviewed by RA | No safe or effective claims |
| Pricing, "order now", "available Q1" | Yes, per MLR | No | No |
| Status line on screen | Not needed | Recommended (see below) | Caution statement required |
| Calls to action | Demo, quote, sales contact | Learn more, demo, scientific discussion | How to apply as an investigator |
The CPG does not prescribe any wording for a pending device. The MD&DI column described "Pending 510(k), not available for sale within the United States" as wording FDA was considering at the time. Many teams still use a line like that because it tells a booth visitor the status in one read. We put it on screen whenever the product is visible, not only on the end card, because people walk into a loop at any second.
The easiest problem to miss in a pending-device loop is not a claim. It's the closing frame: "Talk to your rep about availability," a QR code that opens a quote form, or a launch date framed as a ship date. Each one reads as being prepared to take orders. Swap them for "Visit us for a demo" or a QR code to a product information page with no order path.
What changes for an investigational device
An investigational device is a different conversation. FDA's 1999 guidance on notices of availability of investigational devices (final, issued by CDRH) covers any notice made "through a notice, publication, display, mailing, exhibit, announcement, or oral presentation." A booth screen is a display, so it applies.
Under that guidance, a notice of availability should run only in medical or scientific publications or at medical or scientific conferences whose audience is mainly qualified experts. The content should be limited to four things:
- The proposed use of the device
- The name and address of the sponsor
- How to apply to be an investigator
- How to obtain the device for investigational use
The notice must also carry the caution statement, displayed prominently, in printing at least as large as the largest printing in the notice: "Caution: INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE." The device labeling rule in 21 CFR 812.5 uses the same caution and adds that labeling may not be false or misleading or state or imply that the device is safe or effective for the purposes being investigated.
Video has no "printing," so you have to translate that requirement. Our working reading, which your regulatory team should confirm: the caution appears on screen for the whole time the device or its proposed use is shown, and its type size is at least as large as the largest on-screen text in the loop. That rules out the common layout of a huge headline with a small caution in the lower third. It also tends to push investigational content toward a short, quiet loop rather than a full product film.
A worked example: one loop, two versions
Here is how we would storyboard a 45-second loop for a fictional company, Harbor Line Imaging, showing a fictional CT positioning accessory at a radiology meeting. Version A assumes the 510(k) is pending. Version B assumes the accessory is still in an IDE study.
| Time | Version A: 510(k) pending | Version B: investigational |
|---|---|---|
| 0 to 8 s | Problem statement in plain terms, no outcome numbers. Status line on screen. | Caution statement full width, same size as the title. Proposed use in one line. |
| 8 to 25 s | CAD animation of the accessory and workflow steps. Status line stays visible. | No feature walkthrough. Sponsor name and address. Caution stays visible. |
| 25 to 38 s | Proposed use statement matching the submission word for word. | "Interested in participating as an investigator?" and how to apply. |
| 38 to 45 s | "See it in the booth." QR code to an information page with no order form. | How to obtain the device for investigational use, then loop. |
Notice what Version B leaves out: no animation of results, no comparison to current practice, no "faster" or "safer." The 1997 column also noted that an earlier FDA guideline on investigational notices restricted price information, comparisons and volume discounts. Version B is short on purpose. If marketing wants more on screen, the answer is usually to wait for the decision, not to stretch the notice.
Plan for a fast swap. If the clearance lands before or during the show, you want a cleared version ready to load. We build pending loops with the status line, end card and claims on separate layers so the cleared version is a re-render, not a re-edit. That approach fits our trade show booth video work, and for a project like this one, custom motion graphics built from CAD sits at our Motion level, which starts at $3,200 (see pricing).
Script checklist for a pending or investigational booth loop
Run this on the script and again on the final render. It assumes the device status is already confirmed in writing.
- Status at the top of the scriptWrite "510(k) pending (K number if assigned)" or "Investigational, IDE" on page one so every reviewer reads the same assumption.
- Intended use matches the fileCopy the proposed use from the submission. Do not paraphrase it into something broader for the show audience.
- Status or caution on screenPending: a clear status line whenever the device is visible. Investigational: the full caution statement, at least as large as the largest text, for the full loop.
- No order pathNo prices, quotes, "reserve yours," shipping dates or QR codes that open a purchase or quote form.
- No safe or effective claimsFor investigational devices, none at all. For pending devices, only claims your regulatory team ties to the submission.
- Calls to action fit the statusDemo or scientific discussion for pending. Investigator inquiries for investigational.
- Staff talk track matchesBooth staff say the same thing the screen says. A clean loop does not help if someone at the counter quotes a price.
- Cleared version stagedA separate render with the status layer removed and approved claims added, reviewed in advance, ready if the decision arrives.
Both versions still go through your normal promotional review. Our guide on getting a device video through MLR review in fewer rounds covers how to package a script so reviewers can approve it quickly, and who regulates medical device ads and videos covers the FDA and FTC split once the device is cleared.
Practical timing for a show in five weeks
If you are reading this in late October with RSNA ahead, work backward from the first exhibit day. You need the status confirmed now, a script through review in the next two weeks, and a final render with time for one more review pass. A pending loop is usually simpler to approve than a launch film because it says less. Treat that as an advantage: a short, honest loop with clean visuals and a clear status line does its job at a booth, where many visitors see only part of the loop while walking past.
General information about FDA policy for displaying devices that are not yet cleared or approved. It is not legal or regulatory advice. Confirm your device's status and the right wording with your regulatory and legal teams.
Video summary
Read the on-screen text
Showing a device that isn't cleared yet? Check its status first. 1. 510(k) pending: show it. You may display and advertise it. You may not take or prepare to take orders. 2. Investigational: no promotion. No safe or effective claims. Limit it to a notice for investigators. 3. Caution as large as the title. The caution must be at least as large as the largest text in the notice. 4. Check the end card. No prices, ship dates or QR codes that lead to a quote form. Read the full guide: medtechreel.com/insights
FAQ
Can we display a device with a pending 510(k) at a trade show?
Generally yes. FDA's Compliance Policy Guide Sec. 300.600 says a firm may advertise or display a device that is the subject of a pending 510(k), but may not take orders or be prepared to take orders that might result in contracts of sale, unless limited to research or investigational use.
Is there required wording for a 510(k)-pending booth sign or video?
The CPG does not prescribe wording. Many teams use a line such as "510(k) pending, not available for sale in the United States" so visitors understand the status. Confirm your exact wording with your regulatory team.
Can an investigational device appear in a booth video?
Only in a limited way. FDA's 1999 guidance on notices of availability limits content to the proposed use, the sponsor's name and address, how to apply to be an investigator and how to obtain the device for investigational use, with the caution statement shown prominently. It must not be promoted or described as safe or effective.
What should we do if clearance arrives during the show?
Have a reviewed cleared version of the loop ready to load. Building the status line, end card and claims as separate layers makes that a quick re-render instead of a re-edit.
Sources
- FDA CPG Sec. 300.600: Commercial distribution with regard to premarket notification (510(k))
- 21 CFR 812.7: prohibition of promotion and other practices (Cornell LII)
- 21 CFR 812.5: labeling of investigational devices (Cornell LII)
- FDA guidance: Preparing notices of availability of investigational medical devices and for recruiting study subjects (1999)
- FDA guidance document text (PDF)
- MD&DI: Displaying investigational and unapproved medical devices according to FDA policy (1997)
- RSNA: Planning your exhibit (RSNA 2026 dates and exhibit hours)
- MedTech Reel pricing
Need a video built this way?
Fixed quotes from $1,600, first cuts in about a week, scripts traced to your approved labeling.
Book a 20-minute call
